LYMPHOPROLIFERATION IN PRIMARY SJOGRENS-SYNDROME - EVIDENCE OF SELECTIVE EXPANSION OF A B-CELL SUBSET CHARACTERIZED BY THE EXPRESSION OF CROSS-REACTIVE IDIOTYPES
F. Shokri et al., LYMPHOPROLIFERATION IN PRIMARY SJOGRENS-SYNDROME - EVIDENCE OF SELECTIVE EXPANSION OF A B-CELL SUBSET CHARACTERIZED BY THE EXPRESSION OF CROSS-REACTIVE IDIOTYPES, Arthritis and rheumatism, 36(8), 1993, pp. 1128-1136
Objective. To evaluate the possibility that lymphoproliferation in pri
mary Sjogren's syndrome (SS) arises within a subset of B cells. Method
s. A panel of monoclonal antibodies (MAb) specific for rheumatoid fact
or (RF)-associated cross-reactive idiotypes (CRI) and anti-V(kappa) an
d anti-V(H) subgroup antibodies were used to define the clonality of B
lymphocytes undergoing neoplastic transformation in 5 patients with p
rimary SS. Anti-CRI antibodies were also used to study longitudinal va
riations in serum paraprotein levels and in vitro regulation of IgM an
d IgM-RF production by peripheral blood lymphocytes. The levels of CRI
, IgM, and IgM-RF were quantitated in serum and culture supernatants b
y enzyme-linked immunosorbent assay. Heavy and light chain isotypes an
d V(H) subgroups of the paraproteins were determined by immunoelectrop
horesis, immunofixation, and Western blotting. Results. Paraproteins f
rom all patients expressed an epitope associated with V(kappa)IIIb sub
-subgroup of light chains. Three of the paraproteins were cryoglobulin
s with RF activity, all of which expressed the V(kappa)IIIb-associated
CRI (detected by MAb 17-109) and the V(H)I-associated CRI (detected b
y MAb G6 and G8). None of the paraproteins expressed the V(H)III-assoc
iated CRI (detected by MAb B6 and D12). The CRI were consistently expr
essed over a period of 5-6 years. The anti-CRI and anti-subgroup antib
odies substantially inhibited spontaneous production of IgM-RF and IgM
by peripheral blood B lymphocytes from 3 of the SS patients. Conclusi
on. These results suggest that lymphoproliferation in primary SS is hi
ghly selective, and that the anti-CRI antibodies can be used as an aid
to early diagnosis as well as for monitoring and modulating the lymph
oproliferative process in primary SS.